Post-COVID-19 complications in kidney transplant recipients
- Authors: Shafiekhani M.1, Abolghasemi S.2, Asgharpour M.3, Zare Z.1, Negahban H.2, Akbari R.4, Nikoupour H.1, Roozbeh J.1, Oliaie F.4, Yahyapour Y.4, Geraili Z.4, Barari M.4, Ebrahimpour S.4, Baziboroun M.4,2
-
Affiliations:
- Shiraz University of Medical Sciences
- Shahid Beheshti University of Medical Science
- Rouhani Hospital of Medical Sciences
- Babol University of Medical Sciences
- Issue: Vol 13, No 3 (2023)
- Pages: 559-566
- Section: ORIGINAL ARTICLES
- URL: https://journal-vniispk.ru/2220-7619/article/view/133205
- DOI: https://doi.org/10.15789/2220-7619-PCC-7111
- ID: 133205
Cite item
Full Text
Abstract
Background. Although most people recover from acute COVID-19 within a few weeks, some have long-lasting clinical problems. The prevalence of these prolonged complications in kidney transplant (KT) recipients has not been determined.
Materials and methods. Six months following of 148 patients with post-COVID-19 syndrome admitted to three centers in Iran (Tehran, Shiraz and Babol) that underwent KT were included in this study. Also, one-hundred COVID-19 patients without KT were included as the control group. The demographic data, medications, and disease course were recorded. The baseline and demographic characteristics were analyzed using the Chi-square test. Moreover, student’s t-test were utilized to compare case and control groups.
Results. The total number of patients was 248, of which 148 were in the case groups. Hospitalization associated with COVID-19 was for all patients; besides, there were 18 patients in control and 24 case groups admitted to an intensive care unit (ICU). The most commonly reported symptom was fever. Multivariate analysis identified the history of chronic kidney disease, hypertension, cerebral vascular accident, and diabetes mellites as predictors for developing post-COVID clinical complications.
Conclusion. Evidence shows the high commonness of post-COVID-19 syndrome among kidney transplant patients after COVID-19, and the most common symptoms were fever, chills, and myalgia. So, all patients recovered from acute COVID-19 should undergo long-term monitoring to evaluate and treat possible complications.
Full Text
##article.viewOnOriginalSite##About the authors
Mojtaba Shafiekhani
Shiraz University of Medical Sciences
Email: mojtabashafiekhani@gmail.com
Assistant Professor of Clinical PharmacyShiraz Transplant Center, Abu-Ali Sina Hospital
Iran, Islamic Republic of, ШиразSara Abolghasemi
Shahid Beheshti University of Medical Science
Email: saraabolghasemi1@gmail.com
Assistant Professor of Infectious Disease, Infectious Disease and Tropical Medicine Research Center
Iran, Islamic Republic of, TehranMasoumeh Asgharpour
Rouhani Hospital of Medical Sciences
Email: masi9932002@yahoo.com
Assistant Professor of Nephrology, Department of Nephrology
Iran, Islamic Republic of, BabolZahra Zare
Shiraz University of Medical Sciences
Email: zare_shahrabadi@sums.ac.ir
Student Research Committee, Shiraz Transplant Center, Abu-Ali Sina Hospital
Iran, Islamic Republic of, ShirazHalimeh Negahban
Shahid Beheshti University of Medical Science
Email: rohanresearch88@gmail.com
Fellowship of Infection in immunocompromised and transplant patients, Infectious Disease and Tropical Medicine Research Center
Iran, Islamic Republic of, TehranRoghayeh Akbari
Babol University of Medical Sciences
Email: Roghayeh.akbari@yahoo.com
Associate Professor of Nephrology, Infectious Diseases and Tropical Medicine Research Center, Health Research Institute
Iran, Islamic Republic of, Mazandaran, Babol, Keshavarz BoulevardHamed Nikoupour
Shiraz University of Medical Sciences
Email: nikoupour@gmail.com
Assistant Professor of Hepato Pancreato Biliary Surgery and Abdominal Organ Transplantation, Shiraz Transplant Center, Abu-Ali Sina Hospital
Iran, Islamic Republic of, ShirazJamshid Roozbeh
Shiraz University of Medical Sciences
Email: roozbehj@sums.ac.ir
Professor of Nephrology, Shiraz Transplant Center, Abu-Ali Sina Hospital
Iran, Islamic Republic of, ShirazFarshid Oliaie
Babol University of Medical Sciences
Email: ol_1964@yahoo.com
Associate Professor of Nephrology, Infectious Diseases and Tropical Medicine Research Center, Health Research Institute
Iran, Islamic Republic of, Mazandaran, Babol, Keshavarz BoulevardYousef Yahyapour
Babol University of Medical Sciences
Email: uyahyapoor@yahoo.com
Professor of Medical Virology, Infectious Diseases and Tropical Medicine Research Center, Health Research Institute
Iran, Islamic Republic of, Mazandaran, Babol, Keshavarz BoulevardZahra Geraili
Babol University of Medical Sciences
Email: geraili.stat@yahoo.com
PhD student in Biostatistics, Infectious Diseases and Tropical Medicine Research Center, Health Research Institute
Iran, Islamic Republic of, Mazandaran, Babol, Keshavarz BoulevardMohammad Barari
Babol University of Medical Sciences
Email: rohanresearch8@gmail.com
Student Research Committee, Infectious Diseases and Tropical Medicine Research Center, Health Research Institute
Iran, Islamic Republic of, Mazandaran, Babol, Keshavarz BoulevardSoheil Ebrahimpour
Babol University of Medical Sciences
Email: drsoheil1503@yahoo.com
Assistant Professor of Clinical Sciences (By Research), Infectious Diseases and Tropical Medicine Research Center, Health Research Institute
Iran, Islamic Republic of, Mazandaran, Babol, Keshavarz BoulevardMana Baziboroun
Babol University of Medical Sciences; Shahid Beheshti University of Medical Science
Author for correspondence.
Email: manabaziboron@gmail.com
Fellowship of Infection in immunocompromised and transplant patients,Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences
Iran, Islamic Republic of, Tehran; Mazandaran, Babol, Keshavarz BoulevardReferences
- Aiyegbusi O.L., Hughes S.E., Turner G., Rivera S.C., McMullan C., Chandan J.S., Haroon S., Price G., Davies E.H., Nirantharakumar K., Sapey E., Calvert M.J.; TLC Study Group. Symptoms, complications and management of long COVID: a review. J. R. Soc. Med.,2021, vol. 114, no. 9, pp. 428–442. doi: 10.1177/01410768211032850
- Amin-Chowdhury Z., Harris R.J., Aiano F., Zavala M., Bertran M., Borrow R., Linley E., Ahmad S., Parker B., Horsley A., Hallis B., Flood J., Brown K.E., Amirthalingam G., Ramsay M.E., Andrews N., Ladhani S.N. Characterising post-COVID syndrome more than 6 months after acute infection in adults; prospective longitudinal cohort study, England. medRxiv,2021: 21253633. doi: 10.1101/2021.03.18.21253633
- Anand S., Montez-Rath M., Han J., Bozeman J., Kerschmann R., Beyer P., Parsonnet J., Chertow G.M. Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. Lancet,2020, vol. 396, no. 10259, pp. 1335–1344. doi: 10.1016/S0140-6736(20)32009-2
- Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-covid syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ,2021 vol. 372: n693. doi: 10.1136/bmj.n693
- Baig A.M. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. J. Med. Virol.,2021, vol. 93, no. 5, pp. 2555–2556. doi: 10.1002/jmv.26624
- Basic-Jukic N., Juric I., Furic-Cunko V., Katalinic L., Radic J., Bosnjak Z., Jelakovic B., Kastelan Z. Follow-up of renal transplant recipients after acute COVID-19 — a prospective cohort single-center study. Immun. Inflamm. Dis.,2021, vol. 9, no. 4, pp. 1563–1572. doi: 10.1002/iid3.509
- Carfì A., Bernabei R., Landi F.; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA,2020, vol. 324, no. 6, pp. 603–605. doi: 10.1001/jama.2020.12603
- Chauhan S., Meshram H.S., Kute V., Patel H., Desai S., Dave R. Long-term follow-up of SARS-CoV-2 recovered renal transplant recipients: A single-center experience from India. Transpl. Infect. Dis.,2021, vol. 23, no. 6: e13735. doi: 10.1111/tid.13735
- Fernández-de-Las-Peñas C., Palacios-Ceña D., Gómez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santana M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur. J. Intern. Med.,2021, vol. 92, pp. 55–70. doi: 10.1016/j.ejim.2021.06.009
- Guillen E., Pineiro G.J., Revuelta I., Rodriguez D., Bodro M., Moreno A., Campistol J.M., Diekmann F., Ventura-Aguiar P. Case report of COVID-19 in a kidney transplant recipient: does immunosuppression alter the clinical presentation? Am. J. Transplant.,2020, vol. 20, no. 7, pp. 1875–1878. doi: 10.1111/ajt.15874
- Hasan I., Rashid T., Suliman S., Amer H., Chirila R.M., Mai M.L., Jarmi T., Khouzam S., Franco P.M., Heilig C.W., Wadei H.M. Predictors of disease severity and outcome of hospitalized renal transplant recipients with COVID-19 infection: a systematic review of a globally representative sample. Rom. J. Intern. Med.,2021, vol. 59, no. 1, pp. 10–42. doi: 10.2478/rjim-2020-0034
- Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., Luo J., Huang Z., Tu S., Zhao Y., Chen L., Xu D., Li Y., Li C., Peng L., Li Y., Xie W., Cui D., Shang L., Fan G., Xu J., Wang G., Wang Y., Zhong J., Wang C., Wang J., Zhang D., Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet,2021, vol. 397, no. 10270, pp. 220–232. doi: 10.1016/S0140-6736(20)32656-8
- Johnson K.M., Belfer J.J., Peterson G.R., Boelkins M.R., Dumkow L.E. Managing COVID-19 in renal transplant recipients: a review of recent literature and case supporting corticosteroid-sparing immunosuppression. Pharmacotherapy,2020, vol. 40, no. 6, pp. 517–524. doi: 10.1002/phar.2410
- Kant S., Menez S.P., Hanouneh M., Fine D.M., Crews D.C., Brennan D.C., Sperati C.J., Jaar B.G. The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation. BMC Nephrol.,2020, vol. 21, no. 1: 449. doi: 10.1186/s12882-020-02112-0
- Khairallah P., Aggarwal N., Awan A.A., Vangala C., Airy M., Pan J.S., Murthy B.V.R., Winkelmayer W.C., Ramanathan V. The impact of COVID-19 on kidney transplantation and the kidney transplant recipient — one year into the pandemic. Transpl. Int.,2021, vol. 34, no. 4, pp. 612–621. doi: 10.1111/tri.13840
- Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep.,2021, vol. 11, no. 1: 16144. doi: 10.1038/s41598-021-95565-8
- Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., Ahluwalia N., Bikdeli B., Dietz D., Der-Nigoghossian C., Liyanage-Don N., Rosner G.F., Bernstein E.J., Mohan S., Beckley A.A., Seres D.S., Choueiri T.K., Uriel N., Ausiello J.C., Accili D., Freedberg D.E., Baldwin M., Schwartz A., Brodie D., Garcia C.K., Elkind M.S.V., Connors J.M., Bilezikian J.P., Landry D.W., Wan E.Y. Post-acute COVID-19 syndrome. Nat. Med.,2021, vol. 27, no. 4, pp. 601–615. doi: 10.1038/s41591-021-01283-z
- Negi S., Koreeda D., Kobayashi S., Yano T., Tatsuta K., Mima T., Shigematsu T., Ohya M. Acute kidney injury: epidemiology, outcomes, complications, and therapeutic strategies. Semin. Dial.,2018, vol. 31, no. 5, pp. 519–527. doi: 10.1111/sdi.12705
- Pierce J.D., Shen Q., Cintron S.A., Hiebert J.B. Post-COVID-19 syndrome. Nurs. Res.,2022, vol. 71, no. 2, pp. 164–174. doi: 10.1097/NNR.0000000000000565
- Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., Molteni E., Modat M., Jorge Cardoso M., May A., Ganesh S., Davies R., Nguyen L.H., Drew D.A., Astley C.M., Joshi A.D., Merino J., Tsereteli N., Fall T., Gomez M.F., Duncan E.L., Menni C., Williams F.M.K., Franks P.W., Chan A.T., Wolf J., Ourselin S., Spector T., Steves C.J. Attributes and predictors of long COVID. Nat. Med.,2021, vol. 27, no. 4, pp. 626–631. doi: 10.1038/s41591-021-01292-y
- Sykes D.L., Holdsworth L., Jawad N., Gunasekera P., Morice A.H., Crooks M.G. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung,2021, vol. 199, no. 2, pp. 113–119. doi: 10.1007/s00408-021-00423-z
- Tadbiri H., Moradi-Lakeh M., Naghavi M. All-cause excess mortality and COVID-19-related deaths in Iran. Med. J. Islam. Repub. Iran,2020, vol. 34: 80. doi: 10.34171/mjiri.34.80
- Tielemans M.M., van Boekel G.A.J., van Gelder T., Tjwa E.T., Hilbrands L.B. Immunosuppressive drugs and the gastrointestinal tract in renal transplant patients. Transplant. Rev. (Orlando),2019, vol. 33, no. 2, pp. 55–63. doi: 10.1016/j.trre.2018.11.001
- Townsend L., Dowds J., O’Brien K., Martin-Loeches I., Nadarajan P., Bannan C. Reply: the relation between persistent poor health after COVID-19 and respiratory complications or initial disease severity. Ann. Am. Thorac. Soc.,2021, vol. 18, no. 8, pp. 1431–1432. doi: 10.1513/AnnalsATS.202101-073LE
- Tricot L., Lebbé C., Pillebout E., Martinez F., Legendre C., Thervet E. Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. Transplantation,2005, vol. 80, no. 11, pp. 1546–1549. doi: 10.1097/01.tp.0000181195.67084.94.
Supplementary files
